• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

NeuroSearch A/S

+ Add to Watchlist


0.350 EUR 0.004 1.16%

As of 09:33:01 ET on 11/24/2014.

Snapshot for NeuroSearch A/S (NRS)

Open: 0.352 Day's Range: 0.349 - 0.352 Volume: 0
Previous Close: 0.346 52wk Range: 0.327 - 0.490 1-Yr Rtn: -19.91%

Stock Chart for NRS

No chart data available.
  • NRS:GR 0.350
  • 1D
  • 1M
  • 1Y
Interactive NRS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NRS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (DKK) (ttm) -
Est. EPS (DKK) (12/2014) -
Est. PEG Ratio -
Market Cap (M EUR) 8.59
Shares Outstanding (M) 24.55
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 01/23/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NRS

  • Revenue
  • Net Income (M/DKK)
  • Profit Margin (%)

Company Profile & Key Executives for NRS

NeuroSearch A/S is a bio-pharmaceutical company. The Company researches and develops compounds for the treatment for diseases of the central nervous system such as Huntington's disease, attention deficit disorder, schizophrenia, dyskinesias, cognitive dysfunctions, depression and anxiety, and social anxiety disorder. NeuroSearch also researches treatments for obesity.

Rene SchneiderCEO/CFOFinn Eggert SorensenExec VP/Chief Business Officer
Karin GarreExec VP/Chief Development OfficerMorten Henrik NielsenDir:IT
More Company Profile & Key Executives for NRS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil